& Buvat, J
Semaglutide is administered subcutaneously, meaning the medication is delivered into the fatty tissue layer between skin and muscle
No detectable cross-reactivity to Glucagon, GLP-1, GLP-2, Oxyntomodulin, GRPP, MPGF-1, MPGF-2, Insulin, C-Peptide, or Thyroglobulin
Obesity is a known risk factor for acid reflux, and the weight loss achieved through semaglutide treatment has, in some cases, led to a reduction in acid reflux symptoms
Risk factors for diverticulitis include age (it's most common in people over 50), genetics, ongoing constipation, a low-fiber diet, obesity, smoking, lack of exercise, and certain medications